Skip to content
Clinical Trials – home
Research site

Kliniken Suedostbayern AG

Germany Cuno-Niggl-Strasse 3, 83278 Traunstein, Germany

  • 11 trials recruiting
  • Obesity · Non-small cell lung cancer · Non-small cell lung cancer stage IV
  • Adult patients

About Specializations

Kliniken Suedostbayern AG in Traunstein, Germany specialises in clinical trials of conditions such as Obesity, Non-small cell lung cancer, Non-small cell lung cancer stage IV, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Hemic and Lymphatic Diseases

At Kliniken Suedostbayern AG the hematology‑oncology‑palliative care department concentrates on lymphoma research, with a particular focus on older adults who cannot tolerate full‑dose chemotherapy.

  • Combination therapy with a BTK inhibitor
  • Reduced‑dose chemotherapy strategies
  • Outcomes in patients over 80 years of age
  • Safety profiling in frail populations

Five investigators are leading efforts to improve progression‑free survival for patients with Diffuse large B‑cell lymphoma by testing a new drug‑plus‑chemo regimen.

Neoplasms

The site also addresses a broad spectrum of high‑grade B‑cell lymphomas, including rare variants such as primary mediastinal large B‑cell lymphoma and ALK‑positive large B‑cell lymphoma.

  • Molecular characterization of MYC/BCL2 rearranged lymphomas
  • Evaluation of novel targeted agents
  • Clinical assessment of lymphoma subtypes with viral association
  • Integration of diagnostic biomarkers

Through two active trials, the team aims to refine treatment options and expand therapeutic choices for patients with aggressive neoplasms across Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Cuno-Niggl-Strasse 383278 TraunsteinGermany
Recruiting now
11 trials
Conditions studied
34

More sites in TraunsteinGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

19 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Blinatumomab
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.